JW Life Science

JW Life Science EBIT per Share

The EBIT per Share of JW Life Science (234080.KS) as of Oct 17, 2026 is 2,146.93 KRW. In the previous year, EBIT per Share was 2,278.51 KRW — a change of -5.78% (lower).

EBIT per Share

2,146.93KRW

YoY

-5.78%

Last updated:

EBIT per Share of JW Life Science is 2025 2,146.93 KRW. EBIT per Share of JW Life Science was 2024 2,278.51 KRW. It decreases by -5.78% lower compared to the previous year.

The JW Life Science EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
2,491.42 KRW
Jan 1, 2021
1,835.16 KRW
Jan 1, 2022
1,749.44 KRW
Jan 1, 2023
2,278.51 KRW
Jan 1, 2025
2,146.93 KRW
Jan 1, 2026 (e)
2,421.62 KRW
Jan 1, 2027 (e)
2,573.52 KRW
Jan 1, 2028 (e)
2,748.41 KRW
The JW Life Science EBIT per Share history
YEAREBIT per ShareYoY
est2,748.41KRW+6.80%
est2,573.52KRW+6.27%
est2,421.62KRW+12.79%
2,146.93KRW-5.78%
2,278.51KRW+30.24%
1,749.44KRW-4.67%
1,835.16KRW-26.34%
2,491.42KRW+32.61%
1,878.74KRW+26.37%
1,486.71KRW-0.99%
1,501.55KRW+11.07%
1,351.89KRW+15.94%
1,166.00KRW+27.68%
913.19KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JW Life Science Stock analysis

What does JW Life Science do? JW Life Science Corp is a South Korean pharmaceutical company headquartered in Dangjin. The company manufactures intravenous fluids including basic IV fluids with water, electrolytes, and glucose; nutrient infusion solutions containing amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions for specific medical cases. It also produces total parenteral nutrition (TPN) products. The company went public on October 27, 2016, with its stock listed on the Korea Exchange under ticker 234080.KS. Its ISIN is KR723080000. The company's website is https://www.jw-lifescience.co.kr/ JW Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JW Life Science stock

EBIT per Share of JW Life Science is 2,146.93 KRW in 2025.

EBIT per Share of JW Life Science changed from 2,278.51 KRW to 2,146.93 KRW, representing a -5.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share JW Life Science since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — JW Life Science

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — JW Life Science